Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MBI 226 for Prevention of Catheter-Related Bloodstream Infections
NCT00027248Phase 3Completed
- Sponsor
- BioWest Therapeutics
- Start
- Sep 2000
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of omiganan in catheter-related bloodstream infection (CRBSI), sponsored by BioWest Therapeutics. Started Sep 2000; status: completed.
02
Drugs
omiganan
03
Conditions
catheter-related bloodstream infection (CRBSI)
Beyond the preview
Go deeper on NCT00027248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00027248.